JOHNSON&JOHNSON

The United States has reached a significant milestone in the pandemic, according to the White House. White House COVID-19 coordinator Jeff Zients said during a briefing on Friday that 100 million Americans have now been fully vaccinated against COVID-19, "nearly double" the 55 million Americans who had been fully vaccinated as of the end of March. He later clarified this is the number of Americans who have received both doses of a two-dose vaccine or one dose of a single-dose vaccine. A person is fully vaccinated two weeks after receiving this dose, according to the CDC. "That's 100 million Americans with a sense of relief and peace of mind, knowing that after a long and hard year, they're protected from the virus," Zients said. This comes after the CDC updated its guidelines earlier this week to say that those who have been fully vaccinated against COVID-19 generally no longer need to wear masks outside except when in crowded settings. The 100 million milestone, Zients said, "represents significant progress and cause for hope." "Today, 100 million Americans are fully vaccinated," White House COVID response coordinator Jeff Zients announces. "Nearly double the 55 million who were fully vaccinated at the end of March." pic.twitter.com/F8ST62DIOc — CBS News (@CBSNews) April 30, 2021 More stories from theweek.comRepublicans reveal their red line5 scorchingly funny cartoons about Fox News' meat hysteriaLumber is shockingly expensive. Thanks, Obama.

The United States is recommending a "pause" for the single-dose Johnson & Johnson COVID-19 vaccine to investigate clotting reports.

This September 2020 photo provided by Johnson & Johnson shows vials for a single-dose COVID-19 vaccine being developed by the company. On Friday, Oct. 23, 2020, Johnson & Johnson announced that the Food and Drug Administration is letting it resume testing of its COVID-19 vaccine candidate in the U.S. (Cheryl Gerber/Johnson & Johnson via AP)Johnson & Johnson, which is in clinical trials for its COVID-19 vaccine, says the results have been promising. According to the company, the shot has produced antibodies in nearly all of the participants. Ron DeSantis touted the company’s vaccine, saying it could be a game-changer because it does not need to be kept in ultra-cold storage. Johnson & Johnson is expected to release more data on its vaccine later this month.